Debra Ritzwoller to Prostatic Neoplasms
This is a "connection" page, showing publications Debra Ritzwoller has written about Prostatic Neoplasms.
Connection Strength
0.605
-
Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
Score: 0.175
-
Use of Evidence-Based Prostate Cancer Imaging in a Nongovernmental Integrated Health Care System. J Oncol Pract. 2017 05; 13(5):e441-e450.
Score: 0.119
-
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
Score: 0.116
-
Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2014 Oct; 52(10):e65-73.
Score: 0.101
-
Validation of electronic data on chemotherapy and hormone therapy use in HMOs. Med Care. 2013 Oct; 51(10):e67-73.
Score: 0.094